The Patent Finder

Bioarctic Neuroscience AB

Also on record
Records under this name other than the patents Bioarctic Neuroscience AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.

Showing 1 to 10 of 10 · Back to Bioarctic Neuroscience AB

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,025,878Protofibril Selective Antibodies and the Use Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,084,832Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other α-synucleinopathies
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,573,994Abeta PROTOFIBRIL BINDING ANTIBODIES
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,404,459Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
Term ended
Term ended Jun 21, 2025 · USPTO record
Term endedTerm ended Jun 21, 2025USPTO record
US 8,999,936Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
Term ended
Ended no later than Jun 21, 2025 · USPTO record
Term endedEnded no later than Jun 21, 2025USPTO record
US 9,895,234Spinal cord devices and methods for promoting axonal regeneration
Lapsed on the fee record
Ended Feb 20, 2022 · USPTO record
Lapsed on the fee recordEnded Feb 20, 2022USPTO record
US 7,700,719Arctic β amyloid protofibril
Term ended
Term ended Oct 17, 2021 · USPTO record
Term endedTerm ended Oct 17, 2021USPTO record
US 7,179,463Treatment of alzheimer's disease
Term ended
Term ended Jul 9, 2021 · USPTO record
Term endedTerm ended Jul 9, 2021USPTO record
US 8,409,575Antibodies specific for amyloid beta protofibril
Term ended
Ended no later than Jul 9, 2021 · USPTO record
Term endedEnded no later than Jul 9, 2021USPTO record
US 7,709,695Transgenic mouse expressing arctic mutation E693G
Lapsed on the fee record
Ended May 4, 2018 · USPTO record
Lapsed on the fee recordEnded May 4, 2018USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited